2,5-DMMA
![]() |
- $81 - $632
- Product name: 2,5-DMMA
- CAS: 54687-43-3
- MF: C12H19NO2
- MW: 209.29
- EINECS:
- MDL Number:
- Synonyms:2,5-DMMA;1-(2,5-dimethoxyphenyl)-N-methylpropan-2-amine;Benzeneethanamine, 2,5-dimethoxy-N,α-dimethyl-;2,5-Dimethoxymethamphetamine;Methyl-DMA
4 prices
Selected condition:
Brand
- AK Scientific
- Cayman Chemical
Package
- 5mg
- 10mg
- 50mg
- ManufacturerAK Scientific
- Product number6423CJ
- Product descriptionMethyl-DMA
- Packaging5mg
- Price$187
- Updated2021-12-16
- Buy
- ManufacturerCayman Chemical
- Product number15131
- Product description2,5-DMMA ≥98%
- Packaging5mg
- Price$81
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number15131
- Product description2,5-DMMA ≥98%
- Packaging10mg
- Price$152
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number15131
- Product description2,5-DMMA ≥98%
- Packaging50mg
- Price$632
- Updated2024-03-01
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 6423CJ | Methyl-DMA | 5mg | $187 | 2021-12-16 | Buy |
Cayman Chemical | 15131 | 2,5-DMMA ≥98% | 5mg | $81 | 2024-03-01 | Buy |
Cayman Chemical | 15131 | 2,5-DMMA ≥98% | 10mg | $152 | 2024-03-01 | Buy |
Cayman Chemical | 15131 | 2,5-DMMA ≥98% | 50mg | $632 | 2024-03-01 | Buy |
Properties
Boiling point :146 °C(Press: 5 Torr)
Density :0.985±0.06 g/cm3(Predicted)
solubility :DMF: 33 mg/ml; DMSO: 12 mg/ml; Ethanol: 14 mg/ml; PBS (pH 7.2): 3.3 mg/ml
pka :10.21±0.10(Predicted)
Density :0.985±0.06 g/cm3(Predicted)
solubility :DMF: 33 mg/ml; DMSO: 12 mg/ml; Ethanol: 14 mg/ml; PBS (pH 7.2): 3.3 mg/ml
pka :10.21±0.10(Predicted)
Safety Information
Symbol(GHS): |
![]() ![]() |
||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Danger | ||||||||||||||||||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||||||||||||||||||
Precautionary statements: |
|